Navigation Links
New Biosensor Developed To Detect E. Coli Bacteria

Scientists have developed a biosensor to detect the E. Coli bacteria, an infectious agent that causes food borne illness. The biosensor is said to detect the bacteria rapidly and accurately.//

The unique technology developed by the University of Rochester Medical Centre uses a protein from the suspect bacteria as part of the sensing system that includes a silicon chip and a digital camera, says science portal EurekAlert.

"Traditional methods of detection of bacteria can take days but the biosensor developed by them could take as much time as it takes for a snapshot," said lead researcher Benjamin Miller.

The Rochester team called the technology "arrayed imaging reflectometry".

The system utilises a silicon chip that is made in a manner so that laser light reflected off the chip is invisible unless the target bacteria are present.

A protein from the bacteria, Translocated Intimin Receptor or Tir, is placed on the chip. The Tir can be seen as a "molecular harpoon", Miller said.

The E. Coli sends out the harpoon into a cell. Once it is in, the Tir binds with an E. Coli protein called Intimin. A similar process occurs between the Tir placed on the chip and any E. Coli in the sample.

The binding of the probed sample and the bacteria alters the surface of the chip. A digital camera image of the chip captures the changes for analysis and confirmation of detection.

Describing the new technology as inexpensive, Miller said that a physician some day could use it in his office to confirm a streptococcal infection in a patient with a sore throat.

--Edited IANS
'"/>




Page: 1

Related medicine news :

1. Biosensor chip to help drug development
2. Small Biosensor To Enable Cancer Detection
3. Biosensor Chips to detect Urinary Tract Infections
4. Scientists Developed Map For Brain Molecular Communities
5. Scientists Developed Cheap Way To Assess Sleep
6. Diabetic Friendly Egg Developed In India
7. Three In One Ultrasound Probe For 3-D Imaging Of Heart And Tissue Destruction Developed
8. Cervical Cancer Vaccine To Be Developed In India
9. Anti-Microbial Coating For Use Over Biomedical Devices Developed
10. Cure for Osteoarthritis To Be Developed
11. Mice With Human Thought Processes Could Be Developed In The Future
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2016)... , ... February 13, 2016 , ... Hidden Cypress in Sun City is the place ... facial plastic surgery. Dr. Frederick Weniger will be hosting this educational seminar from ... event, and there will be special pricing on offers. In addition, prizes will be given ...
(Date:2/13/2016)... (PRWEB) , ... February 13, 2016 , ... The producers ... impact of American businesses. , The increasingly modern world of instantaneous consumption proves ... on non-renewable energy sources such as oil and coal, which pollutes our air, water, ...
(Date:2/13/2016)... ... 13, 2016 , ... DDi , a Makro company, ... for its expertise in eClinical Solutions. DDi has built its solution competency with ... of global clients. DDi provides smarter technology for Clinical Development, Regulatory and Enterprise ...
(Date:2/12/2016)... ... February 12, 2016 , ... The Lymphoma ... innovative lymphoma research and serving the lymphoma community through a comprehensive series of ... South Florida’s philanthropic community at its 10th anniversary Fashion Luncheon on Monday, February ...
(Date:2/12/2016)... , ... February 12, 2016 , ... Coco Libre, the ... in Red Carpet Events LA GRAMMY’s Style Lounge Event. Coco Libre will offer musicians ... stay hydrated before the big event. The invitation-only gifting suite, held this year at ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... and Company (NYSE: LLY ) today announced that the ... patent would not presently be infringed by Actavis marketing pemetrexed ... Italy and Spain ... --> --> In ... Lilly,s patent would be indirectly infringed by Actavis marketing certain ...
(Date:2/12/2016)... , Feb. 12, 2016  Apellis Pharmaceuticals, ... a $47.1 million Series D preferred stock ... Management, Hillhouse Capital Group and venBio Global ... Investments, AJU IB Investment, and Epidarex Capital. The ... to further advance clinical trials in the ...
(Date:2/11/2016)... , Feb. 11, 2016 The primary goal ... future adoption patterns on the usage of liquid biopsy. ... following: - Timeframe of liquid biopsy adoption ... cfDNA and Evs—by organization type - Sample inflow to ... blood, saliva, stool, serum, and so on. - Correlation ...
Breaking Medicine Technology: